- Strong Financial Performance: Sabesp reported a net income of R$1.21 billion in the second quarter of 2024, representing a 63% increase year-over-year.
- Exceeding Estimates: The net income surpassed analysts’ estimates of R$998.8 million.
- Revenue Growth: Net operating revenue reached R$6.75 billion, marking a 9.7% increase compared to the previous year.
- Revenue Above Expectations: The reported net operating revenue was above the estimated R$5.81 billion.
- Adjusted EBITDA: The adjusted EBITDA for the quarter was R$2.97 billion, exceeding the estimate of R$2.59 billion.
- Market Sentiment: Analysts’ recommendations include 13 buys, 3 holds, and no sells.
A look at Cia Saneamento Basico De Sp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Investors looking at the long-term outlook for Cia Saneamento Basico De Sp, based on the Smartkarma Smart Scores, can see a positive trend ahead. With a Growth score of 4 and a Momentum score of 5, the company is positioned well for potential expansion and market performance. This indicates a strong potential for growth and an existing positive momentum that may continue in the foreseeable future.
Cia Saneamento Basico De Sp also shows decent scores in Value (2), Dividend (2), and Resilience (3), which provides a well-rounded view of its overall outlook. As a company that focuses on water collection, treatment, and distribution infrastructure, it stands to benefit from a sector that is essential for communities. Overall, with favorable scores across key factors, Cia Saneamento Basico De Sp could be seen as a promising investment choice for the future.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
